Clinical trial

Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple Sclerosis

NCT01065727

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-03-01

PhaseNA

Study timeline

Study start (actual)2010-03-01Date precision: month

Registry last updated2026-06-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

mitoxantrone - immunomodulatorOTHER

natalizumabOTHER

Sponsors & collaborators

Rennes University Hospitallead sponsor

Mapped research locations

RennesFrance1 BrestFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01065727 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.